55 filings
Page 3 of 3
8-K
f9v0k0erdx9z3z4k6t
5 Nov 15
OncoMed Pharmaceuticals Reports Third Quarter 2015
12:00am
8-K
qn2tzcwy ic2
10 Aug 15
OncoMed Pharmaceuticals Announces Second Quarter 2015 Financial Results and Updates Demcizumab Phase 1b Non-Small Cell Lung Cancer Survival Data
12:00am
8-K
1q3yy f2l76vfe
29 Jun 15
OncoMed Pharmaceuticals Appoints Rick Winningham to Board of Directors
12:00am
8-K
fjg2yb lg4j8vd14qpjl
25 Jun 15
Submission of Matters to a Vote of Security Holders
12:00am
8-K
gcu3em53dd5k dn
7 May 15
OncoMed Pharmaceuticals Announces First Quarter 2015 Financial Results
12:00am
8-K
a1tzadi t3
29 Apr 15
Regulation FD Disclosure
12:00am
8-K
7fszo xk6
12 Mar 15
OncoMed Pharmaceuticals Reports Full Year and Fourth Quarter 2014 Financial Results and Recent Highlights
12:00am
8-K
7aoap4mf21szhdus7u
12 Jan 15
Results of Operations and Financial Condition
12:00am
8-K
68go0a8 5bzdq
4 Nov 14
OncoMed Pharmaceuticals Announces Third Quarter 2014 Financial and Operating Results
12:00am
8-K
ql2 xztjc7kh2yoc4ng
19 Jun 14
Submission of Matters to a Vote of Security Holders
12:00am
8-K
whabveuvke71bi9
18 Mar 14
OncoMed Pharmaceuticals Announces Full Year and Fourth Quarter 2013 Financial Results
12:00am
8-K
oxylqnn
3 Dec 13
OncoMed to Receive $177.25 Million Upfront, Including a $22.25 Million Equity Investment
12:00am
8-K
92gxtjh
12 Nov 13
OncoMed Pharmaceuticals Announces Third Quarter 2013 Financial Results
12:00am
8-K
fy1euqgwqb
17 Oct 13
OncoMed Pharmaceuticals Appoints Michael Wyzga to Board of Directors
12:00am
8-K
zjy0di
23 Jul 13
Amendments to Articles of Incorporation or Bylaws
12:00am